Gadofosveset enhanced MR phlebography for detecting pelvic and deep vein leg thrombosis,;MR-phlebographie mit gadofosveset zur darstellung tiefer becken-und beinvenenthrombosen

Vasa - Journal of Vascular Diseases

Volumn 40, Issue 4, 2011, Pages 315-319

  Partovi, S ^a   Aschwanden, M ^a   Staub, D ^a   Rasmus, M ^a   Zipp, L ^a   Rengier, F ^b   Jacobi, B ^c   Hugli R ^d   Bilecen, D ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d University Hospital Bruderholz   (Czech Republic)

Author keywords

Deep vein thrombosis; Gadofosveset; MR phlebography

Indexed keywords

GADOFOSVESET;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FEMALE; HUMAN; LEG THROMBOSIS; LOWER EXTREMITY DEEP VEIN THROMBOSIS; MAGNETIC RESONANCE PHLEBOGRAPHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY ADENOCARCINOMA; PELVIC THROMBOSIS; PHLEBOGRAPHY; POPLITEAL THROMBOSIS; RADIODIAGNOSIS; THROMBOSIS; UPPER EXTREMITY DEEP VEIN THROMBOSIS;

EID: 79960776531     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526/a000121     Document Type: Article

References (13)

1. Bounameaux H, Righini M, Perrier A. Venous thromboembolism: Contemporary diagnostic and therapeutic aspects. VASA 2008; 37 (3): 211-26.
2. Enden T, Storås TH, Negård A, Haig Y, Sandvik L, Gjesdal KI, Sandset PM, Kløw NE. Visualization of Deep Veins and Detection of Deep Vein Th rombosis (DVT) With Balanced Turbo Field Echo (b-TFE) and Contrast-Enhanced T1 Fast Field Echo (CE-FFE) Using a Blood Pool Agent (BPA). J Mag Reson Imaging 2010; 31 (2): 416-24.
3. Goyen M. Gadofosveset: the first intravascular contrast agent EUapproved for use with magnetic resonance angiography. Future Cardiol 2007; 3: 19-26.
4. Hansch A, Betge S, Poehlmann G, Neumann S, Baltzer P, Pfeil A, Waginger M, Boettcher J, Kaiser WA, Wolf G, Mentzel HJ. Combined magnetic resonance imaging of deep venous thrombosis and pulmonary arteries aft er a single injection of a blood pool contrast agent. Eur Radiol 2011, 21: 318-25.
5. Hartmann M, Wiethoff AJ, Hentrich HR, Rohrer M. Initial imaging recommendations for Vasovist angiography. Eur Radiol 2006; 16 Suppl 2:B15-23.
6. Hochuli M, Duewell S, Frauchiger B. Quantitative d-dimer levels and the extent of venous thromboembolism in CT angiography and lower limb ultrasonography. VASA 2007; 36 (4): 267-74.
7. Krüger K, Wildberger J, Haage P, Landwehr P. Diagnostic imaging of venous disease: Part I: methods in the diagnosis of veins and thrombosis. Radiologe 2008; 48 (10): 977-92.
8. Palareti G, Cosmi B, Legnani C. Diagnosis of deep vein thrombosis. Semin Thromb Hemost 2006; 32: 659-72.
9. Parmelee DJ, Walovitch RC, Ouellet HS, Lauff er RB. Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. InvestRadiol 1997; 32 (12): 741-7.
10. Ruehm SG, Wiesner W, Debatin JF. Pelvic and lower extremity veins: contrast-enhanced threedimensional MR venography with a dedicated vascular coil-initial experience. Radiology 2000; 215: 421-7.
11. Schellong SM, Schwarz T, Pudollek T, Schmidt B, Schroeder HE. Complete compression ultrasound for the diagnosis of proximal and distal deep venous thrombosis-a retrospective outcome study. VASA 2001; 30 (4): 253-7.
12. Spritzer CE, Arata MA, Freed KS. Isolated pelvic deep venous thrombosis: relative frequency as detected with MR imaging. Radiology 2001; 219 (2): 521-5.
13. Vosshenrich R., Reimer P. Nephrogenic systemic fibrosis. VASA 2009; 38 (1): 31-8.